期刊文献+

口服蛋白制剂及其对肝脏疾病的作用 被引量:1

Introduction of Oral Protein Preparations and Their Effect on Liver Disease
下载PDF
导出
摘要 肝病群体数字庞大,患者治疗过程往往周期长、治愈难、预后差。早期开展营养支持疗法,纠正病人已经存在的营养不良,防止进展期肝病病人低蛋白血症的发生,这可以通过口服蛋白肽来调节机体免疫,可修复、再生肝细胞、恢复肝功能。 The number of liver disease patients is huge, The patients usually suffer from a long period of treatment, but still find it difficult to be completely cured and the results are not satisfactory. The nutrition supporting therapy should be started in the early stage, so as to correct the malnutrition of patients and prevent the occurrence of hypoproteinemia on liver disease patients during the developing period, This can be done with the help of protein peptide which modulates the immune function and thus realize the recovery of injured liver cells, cell regeneration and the recovery of liver function.
作者 汪友永
出处 《抗感染药学》 2006年第4期145-148,共4页 Anti-infection Pharmacy
关键词 肝脏疾病 口服蛋白制剂 经肠营养 支持疗法 Liver disease oral protein preparation enteral nutrition supporting therapy
  • 相关文献

参考文献10

二级参考文献82

  • 1梁晓峰,陈园生,王晓军,贺雄,陈丽娟,王骏,林长缨,白呼群,严俊,崔钢,于竞进.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志,2005,26(9):655-658. 被引量:967
  • 2慢性乙型肝炎防治指南[J].中华传染病杂志,2005,23(6):421-431. 被引量:824
  • 3Vincenzini M T, Iantomasi T,Favilli F. Glutathione transportcross intestinal brush - border membranes: effects of ions, pH,and inhibitors. Biochemistry Biophysics Acat, 1989 (987) : 29-37.
  • 4Morttnhews D W. Peptides absorption: A review of current concepts and future perspectives. J.Anim. Sci, 1992(70) :3248-3257.
  • 5Boza J J, Moennoz D, Vuichoud J, et al. Protein hydrolysate vs free amino acid- based diets on the nutritional recovery of the starved rat. European Journal of Nutrion, 2000, 39 (6): 237-243.
  • 6[11]Iwanaga K, Ono S, Narioka K, et al. Application of surface-coated liposomes for oral deliwry of peptide: dfects of coating the liposome′s surface on the GI transit of Insulin. J Pharm Sci, 1999;88(2):248-252
  • 7[12]Kisel M A, Kulik L N, Tsybovsky, et al. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: study in the rat. Int J Pharm,2001 ; 216(1-2) :105-114
  • 8[13]Tobio M, Gref R , Sanchez A, et al. Stealth PLA-PEG nanoparticles as protein carries for masal administration. Pharm Res, 1998; 15 (2):270 -275
  • 9[14]Labhasetwar V, Song C, Levy R J. Nanoparticle drug delivery system for restenosis. Adv Drug Dev Rev,1997;24(1):63-85
  • 10[15]Fattal E, Vauthier C, Aynie I, et al. Biogegradable polyalkylcyanoacylate nanoparticles for thedelivery of oligonucleotides. Journal of Controlled Release, 1998;53( 1- 3 ): 137- 143

共引文献63

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部